General Information of the Compound
| Compound ID |
CP0398315
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
tert-butyl N-[N'-[4-[2-[(4-anilino-1-benzylpiperidin-4-yl)methylamino]-2-oxoethyl]phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]carbamate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H50N6O5
|
||||||||||||||||||
| Molecular Weight |
670.855
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)OC(=O)N\C(Nc1ccc(CC(=O)NCC2(CCN(Cc3ccccc3)CC2)Nc2ccccc2)cc1)=N/C(=O)OC(C)(C)C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H50N6O5/c1-36(2,3)48-34(46)41-33(42-35(47)49-37(4,5)6)40-30-19-17-28(18-20-30)25-32(45)39-27-38(43-31-15-11-8-12-16-31)21-23-44(24-22-38)26-29-13-9-7-10-14-29/h7-20,43H,21-27H2,1-6H3,(H,39,45)(H2,40,41,42,46,47)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LDNMAXFHEGNPFK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04406, Neuropeptide FF receptor 1
Protein ID: PT02666, Neuropeptide FF receptor 2